Atlassian (NASDAQ:TEAM) Given New $95.00 Price Target at UBS Group

Key Points

• UBS lowered its price target for Atlassian to $95 and kept a "neutral" rating, implying roughly a 6.9% upside, while the analyst consensus target remains much higher at $144.67 (overall "Moderate Buy").
• Shares surged 29.6% to $88.88 on heavy volume after Atlassian beat Q3 estimates (EPS $1.22 vs $1.12; revenue $1.59B, +23.3% YoY) and highlighted cloud and AI momentum, though margins are negative and valuation risks persist.
• Insiders sold about 52,003 shares (~$5.34M) recently (including CTO and CRO transactions), while institutional ownership is very high at roughly 94.45%.

Atlassian (NASDAQ:TEAM - Get Free Report) had its price objective reduced by equities researchers at UBS Group from $105.00 to $95.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a "neutral" rating on the technology company's stock. UBS Group's price target would indicate a potential upside of 6.89% from the company's previous close.

A number of other brokerages have also recently weighed in on TEAM. Weiss Ratings reissued a "sell (e+)" rating on shares of Atlassian in a report on Monday, April 20th. Robert W. Baird set a $120.00 target price on shares of Atlassian in a report on Friday. Guggenheim set a $115.00 price target on shares of Atlassian in a research report on Thursday, April 9th. BTIG Research set a $120.00 price target on shares of Atlassian and gave the stock a "buy" rating in a research report on Friday. Finally, Cantor Fitzgerald upped their price target on shares of Atlassian from $98.00 to $107.00 and gave the stock an "overweight" rating in a research report on Friday. Twenty-one research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Atlassian currently has an average rating of "Moderate Buy" and a consensus target price of $144.67.

Atlassian Stock Up 29.6%

Shares of NASDAQ TEAM traded up $20.29 during trading on Friday, reaching $88.88. 27,352,585 shares of the stock were exchanged, compared to its average volume of 6,973,472. The business's 50-day moving average price is $70.97 and its 200 day moving average price is $118.12. Atlassian has a twelve month low of $56.01 and a twelve month high of $232.36. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $23.44 billion, a price-to-earnings ratio of -123.44 and a beta of 0.99.

Atlassian (NASDAQ:TEAM - Get Free Report) last posted its earnings results on Friday, February 6th. The technology company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.12 by $0.10. The business had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $1.54 billion. Atlassian had a negative net margin of 3.29% and a negative return on equity of 6.33%. The business's revenue for the quarter was up 23.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.96 earnings per share. As a group, equities analysts forecast that Atlassian will post -0.01 EPS for the current fiscal year.

Insider Buying and Selling at Atlassian

In other news, CTO Rajeev Bashyam Rajan sold 3,072 shares of the firm's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $81.35, for a total transaction of $249,907.20. Following the completion of the sale, the chief technology officer directly owned 212,916 shares of the company's stock, valued at $17,320,716.60. This trade represents a 1.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CRO Brian Duffy sold 1,222 shares of the firm's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $81.35, for a total value of $99,409.70. Following the sale, the executive directly owned 124,332 shares of the company's stock, valued at approximately $10,114,408.20. This represents a 0.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 52,003 shares of company stock worth $5,338,804. 36.66% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. MV Capital Management Inc. purchased a new position in shares of Atlassian in the fourth quarter worth approximately $25,000. Physician Wealth Advisors Inc. increased its position in shares of Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company's stock worth $26,000 after acquiring an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp increased its position in shares of Atlassian by 19,900.0% in the third quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company's stock worth $32,000 after acquiring an additional 199 shares in the last quarter. Board of the Pension Protection Fund purchased a new position in shares of Atlassian in the fourth quarter worth approximately $32,000. Finally, Basepoint Wealth LLC purchased a new stake in shares of Atlassian in the fourth quarter worth approximately $32,000. 94.45% of the stock is owned by hedge funds and other institutional investors.

Atlassian News Summary

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: Q3 beat and raised guidance — Atlassian reported stronger-than-expected Q3 results (revenue growth ~32%, EPS above estimates) and lifted FY revenue growth guidance to ~24%, a key driver of the share rally. Read More.
• Positive Sentiment: Cloud + AI momentum — Management highlighted accelerated cloud migrations and AI-enabled product features (Rovo and other integrations) as the growth engine behind recurring subscription strength and margin improvements. Read More.
• Positive Sentiment: Analyst and sector reaction — Several analysts praised the results and lifted tone on beaten-down SaaS names; the beat helped trigger broader software sector relief trades and buy calls from some firms. Read More.
• Positive Sentiment: Product ecosystem expansion — Atlassian Ventures investment in Riffle and Marketplace activity signal continued partner/AI ecosystem growth, supporting longer‑term enterprise adoption. Read More.
• Neutral Sentiment: Price target adjustments — Some banks trimmed price targets (e.g., Piper Sandler lowered its target while keeping an overweight rating), reflecting mixed outlooks on valuation despite the beat. Read More.
• Neutral Sentiment: Mixed Wall Street takes — While many applauded the quarter, other analysts raised questions about whether cloud wins are enough to offset broader software compression and to sustain multi‑year growth cadence. Read More.
• Negative Sentiment: Valuation and volatility remain concerns — Despite the rally, TEAM has seen steep prior declines and still faces scrutiny on margins, data‑center dynamics and long‑term valuation; investors should weigh the beat against continued execution risks. Read More.

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian's product portfolio centers on tools designed to help teams plan, build and support software and business processes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.